← Back to Search

Live Long Walk Strong Program for Limited Mobility (LLWS Trial)

N/A
Recruiting
Led By Jonathan F. Bean, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 50 and older
Usual gait speed 0.5 m/s- 1.0 m/s
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks of intervention end
Awards & highlights

LLWS Trial Summary

This trial will test if the Live Long Walk Strong program can help improve Veterans' gait speed, and what features of the program contribute to this improvement.

Who is the study for?
This trial is for Veterans aged 50 or older with limited mobility, specifically those who can walk at a usual pace of 0.5 m/s to 1.0 m/s, live in the community, and can communicate in English. They must be able to modify activities and have access to telehealth rehabilitation. Those with severe physical impairments, recent major medical events, planned surgeries, cognitive issues or terminal diseases cannot participate.Check my eligibility
What is being tested?
The study tests the Live Long Walk Strong (LLWS) rehab program's effectiveness on improving walking speed among older Veterans with mobility limitations. It also looks into which aspects of the program are most beneficial for enhancing gait speed.See study design
What are the potential side effects?
Since this is a rehabilitation program rather than a drug treatment, side effects may include muscle soreness or fatigue due to exercise. However, specific side effects will depend on individual health conditions and responses to the exercises.

LLWS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.
Select...
I walk at a slow to moderate pace.

LLWS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks of intervention end
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 weeks of intervention end for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gait Speed
Secondary outcome measures
Gait Variability
Lower Extremity Power
Trunk Muscle Endurance
Other outcome measures
Adherence
Cognition
Compliance

LLWS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Live Long Walk StrongExperimental Treatment1 Intervention
8 week rehabilitation program
Group II: 8 week wait list controlActive Control1 Intervention
8 week wait list then followed by 8 weeks of the Live Long Walk Strong rehabilitation program

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,086 Total Patients Enrolled
Jonathan F. Bean, MDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Media Library

Live Long Walk Strong rehabilitation program Clinical Trial Eligibility Overview. Trial Name: NCT04026503 — N/A
Limited Mobility Research Study Groups: 8 week wait list control, Live Long Walk Strong
Limited Mobility Clinical Trial 2023: Live Long Walk Strong rehabilitation program Highlights & Side Effects. Trial Name: NCT04026503 — N/A
Live Long Walk Strong rehabilitation program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04026503 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for the trial still open?

"According to clinicaltrials.gov, this medical trial is currently recruiting participants. Initially posted on October 1st 2020 and recently updated on May 17th 2022, the study seeks qualified candidates."

Answered by AI

How many participants has the research team accepted into this trial?

"Indeed, according to the information held on clinicaltrials.gov, this research is currently searching for volunteers. It was initially published on October 1st 2020 and updated as recently as May 17th 2022. The trial requires 198 participants from a single centre."

Answered by AI
~22 spots leftby Sep 2024